These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6287130)

  • 1. Multiple opioid receptors.
    Iwamoto ET; Martin WR
    Med Res Rev; 1981; 1(4):411-40. PubMed ID: 6287130
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential tolerance and cross-tolerance to chronic treatment with mu and kappa opioid agonists in the rat.
    Young GA; Khazan N
    NIDA Res Monogr; 1984 Mar; 49():121-7. PubMed ID: 6090915
    [No Abstract]   [Full Text] [Related]  

  • 3. Discriminative stimulus properties of nalorphine in the rhesus monkeys.
    Tang AH; Code RA
    J Pharmacol Exp Ther; 1983 Dec; 227(3):563-9. PubMed ID: 6317838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EEG-behavioral dissociation after morphine-and cyclazocine-like drugs in the dog: further evidence for two opiate receptors.
    Pickworth WB; Sharpe LG
    Neuropharmacology; 1979 Jul; 18(7):617-22. PubMed ID: 226904
    [No Abstract]   [Full Text] [Related]  

  • 6. Bremazocine: a potent, long-acting opiate kappa-agonist.
    Römer D; Büscher H; Hill RC; Maurer R; Petcher TJ; Welle HB; Bakel HC; Akkerman AM
    Life Sci; 1980 Sep; 27(11):971-8. PubMed ID: 6253759
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of mu- and kappa-opioid receptor agonists on urinary output in mice.
    Rathbun RC; Kattau RW; Leander JD
    Pharmacol Biochem Behav; 1983 Nov; 19(5):863-6. PubMed ID: 6316374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu opiate isoreceptors: differentiation with kappa agonists.
    Wood PL; Richard JW; Thakur M
    Life Sci; 1982 Nov 15-22; 31(20-21):2313-7. PubMed ID: 6131359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that the discriminative stimulus properties of fentanyl and ethylketocyclazocine are mediated by an interaction with different opiate receptors.
    Shearman GT; Herz A
    J Pharmacol Exp Ther; 1982 Jun; 221(3):735-9. PubMed ID: 6283060
    [No Abstract]   [Full Text] [Related]  

  • 10. Discriminative stimulus properties of narcotic and non-narcotic drugs in rats trained to discriminate opiate kappa-receptor agonists.
    Shearman GT; Herz A
    Psychopharmacology (Berl); 1982; 78(1):63-6. PubMed ID: 6292982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal analgesia: comparison of the mu agonist morphine and the kappa agonist ethylketazocine.
    Wood PL; Rackham A; Richard J
    Life Sci; 1981 May; 28(19):2119-25. PubMed ID: 6114371
    [No Abstract]   [Full Text] [Related]  

  • 12. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog.
    Gilbert PE; Martin WR
    J Pharmacol Exp Ther; 1976 Jul; 198(1):66-82. PubMed ID: 945350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mu, but not kappa, opioid agonists induce contractions of the canine small intestine ex vivo.
    Hirning LD; Porreca F; Burks TF
    Eur J Pharmacol; 1985 Feb; 109(1):49-54. PubMed ID: 2986990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A kappa opioid effect: increased urination in the rat.
    Leander JD
    J Pharmacol Exp Ther; 1983 Jan; 224(1):89-94. PubMed ID: 6294284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential cross-tolerance among morphine, methadone, and ethylketocyclazocine--EEG and behavior.
    Hong O; Young G; Khazan N
    NIDA Res Monogr; 1986; 67():170-6. PubMed ID: 2875392
    [No Abstract]   [Full Text] [Related]  

  • 17. Delineation of mu-antagonist, partial kappa agonist and non-opioid agonist activity of cyclazocine using urinary output of rats.
    Leander JD
    Pharmacol Biochem Behav; 1987 Apr; 26(4):705-7. PubMed ID: 3037567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dynorphin: analgesic effect via kappa receptors in spinal cord of the spinal cords of rats].
    Xie GX; Han JS
    Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):231-4. PubMed ID: 6152645
    [No Abstract]   [Full Text] [Related]  

  • 19. Simple in vivo tests that differentiate prototype agonists at opiate receptors.
    Cowan A
    Life Sci; 1981 Apr; 28(14):1559-70. PubMed ID: 6264252
    [No Abstract]   [Full Text] [Related]  

  • 20. Differentiation between mu and kappa receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis.
    Bertalmio AJ; Woods JH
    J Pharmacol Exp Ther; 1987 Nov; 243(2):591-7. PubMed ID: 2824753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.